Recurrent Pregnancy Loss Association (RPLA) Research Award supports researchers and clinicians investigating recurrent pregnancy loss to deepen understanding of its causes, diagnosis, and management.
Funder: American Society for Reproductive Medicine
Due Dates: March 20, 2027, at 4:00 PM EST (Application) | May 2027 (Notification) | June 2027 (Funding disbursement)
Funding Amounts: Up to $40,000 for a two-year study period
Summary: Supports innovative research and clinical investigations into the causes, diagnosis, management, and pathogenesis of recurrent pregnancy loss.
Key Information: Fellows and postdoctoral trainees must complete their projects before their training programs end.
The Recurrent Pregnancy Loss Association (RPLA), in partnership with the American Society for Reproductive Medicine (ASRM), offers this annual award to support new or ongoing research and clinical investigations into recurrent pregnancy loss. Projects may address physiological, psychological, biochemical, pharmacological, genetic, environmental, or pathological aspects of the condition.
The partnership seeks to advance reproductive medicine, deepen understanding of recurrent pregnancy loss, and enable innovative investigations into unexplained early pregnancy loss. It also aims to increase awareness and attention to early miscarriage and awareness of RPLA among ASRM members. The ASRM Research Institute reviews proposals in collaboration with RPLA-appointed representatives, and recipients share their findings at an ASRM Congress.